The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
New drugs for asthma
Open accessAbstract
Current therapy for asthma with inhaled corticosteroids and long-acting inhaled β(2)-agonists is highly effective, safe, and relatively inexpensive, but many patients remain poorly controlled. Most advances have been through improving these drug classes and a major developmental hurdle is to improve existing drug classes. Major unmet needs include better treatment of severe asthma (which has some similarity to chronic obstructive pulmonary disease), as well as curative therapies for mild to moderate asthma that do not result in the return of symptoms when the treatment is stopped. Several new treatments are in development, but many are specific, targeting a single mediator or receptor, and are unlikely to have a major clinical impact, although they may be effective in specific asthma phenotypes (endotypes). Drugs with more widespread effects, such as kinase inhibitors, may be more effective but have a greater risk of side effects so inhaled delivery may be needed. Several new treatments target the underlying allergic/immune process and would treat concomitant allergic diseases. Improved immunotherapy approaches have the potential for disease modification, although prospects for a cure are currently remote.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Adcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 140
Self-citationRetractedInterleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Leckie, M. J., Brinke, A. T., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A. K., Cowley, H. C., Chung, K. F., Djukanovic, R., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03496-6 · Cited by 1,814
Self-citationJonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,221
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Regular inhaled beta-agonist treatment in bronchial asthma
Sears, M. R., Taylor, D. R., Print, C. G., Lake, D. C., Li, Q., Flannery, E. M., Yates, D. M., Lucas, M. K., & Herbison, G. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)93098-a · Cited by 1,065
Kuperman, D. A., Huang, X., Koth, L. L., Chang, G. H., Dolganov, G. M., Zhu, Z., Elias, J. A., Sheppard, D., & Erle, D. J. (2002) · Nature Medicine · doi:10.1038/nm734 · Cited by 937
The IL-12 Family of Heterodimeric Cytokines
Trinchieri, G., Pflanz, S., & Kastelein, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00296-6 · Cited by 922
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Jutel, M., Akdis, M., Budak, F., Aebischer‐Casaulta, C., Wrzyszcz, M., Blaser, K., & Akdis, C. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200322919 · Cited by 915
Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of asthma
Wegner, C. D., Gundel, R. H., Reilly, P., Haynes, N., Letts, L. G., & Rothlein, R. (1990) · Science · doi:10.1126/science.1967851 · Cited by 898
Beavo, J. A., & Reifsnyder, D. H. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90066-h · Cited by 849
Exhaled Markers of Pulmonary Disease
KHARITONOV, S. A., & BARNES, P. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2009041 · Cited by 844
Self-citationTreatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
Natalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808
Flood-Page, P. T., Menzies-Gow, A. N., Kay, A. B., & Robinson, D. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-789oc · Cited by 808
Sirolimus: its discovery, biological properties, and mechanism of action
Sehgal, S. N. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00211-2 · Cited by 779
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Chemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature Reviews Immunology · doi:10.1038/nri722 · Cited by 752
Efficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Self-citationProstaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Anti-inflammatory actions of steroids: molecular mechanisms
Barnes, P. J., Adcock, I., Spedding, M., & Vanhoutte, P. M. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90184-l · Cited by 725
Self-citationPhosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
Inhaled Glucocorticoids for Asthma
Barnes, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321307 · Cited by 629
Self-citationDevelopment of Spontaneous Airway Changes Consistent with Human Asthma in Mice Lacking T-bet
Finotto, S., Neurath, M. F., Glickman, J. N., Qin, S., Lehr, H. A., Green, F. H. Y., Ackerman, K., Haley, K., Galle, P. R., Szabo, S. J., et al. (2002) · Science · doi:10.1126/science.1065544 · Cited by 627
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 576
The health economics of asthma and rhinitis. I. Assessing the economic impact
Weiss, K. B., & Sullivan, S. D. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112262 · Cited by 543
Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Early Thickening of the Reticular Basement Membrane in Children with Difficult Asthma
Payne, D. N. R., Rogers, A. V., Ädelroth, E., Bandi, V., Guntupalli, K. K., Bush, A., & Jeffery, P. K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-414oc · Cited by 512
Cyclic nucleotide phosphodiesterases
Essayan, D. M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.119555 · Cited by 503
Kips, J. C., O'Connor, B. J., Langley, S. J., Woodcock, A., Kerstjens, H. A. M., Postma, D. S., Danzig, M., Cuss, F., & Pauwels, R. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-525oc · Cited by 494
Interleukin-10 regulation in normal subjects and patients with asthma
Borish, L., Aarons, A., Rumbyrt, J., Cvietusa, P., Negri, J., & Wenzel, S. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70197-5 · Cited by 492
Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells
Hofstra, C. L., Desai, P. J., Thurmond, R. L., & Fung-Leung, W.-P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046581 · Cited by 469
Schäcke, H., Schottelius, A., Döcke, W.-D., Strehlke, P., Jaroch, S., Schmees, N., Rehwinkel, H., Hennekes, H., & Asadullah, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0300372101 · Cited by 466
Nicholson, C. D., Challiss, R. A. J., & Shahid, M. H. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90484-a · Cited by 457
Steinke, J. W., & Borish, L. (2001) · Respiratory Research · doi:10.1186/rr40 · Cited by 444
Saleh, D., Ernst, P., Lim, S., Barnes, P. J., & Giaid, A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.929 · Cited by 437
Self-citationTaylor, I. K., O'Shaughnessy, K. M., Fuller, R. W., & Dollery, C. (1991) · The Lancet · doi:10.1016/0140-6736(91)90277-v · Cited by 433
Gonzalo, J. A., Lloyd, C. M., Kremer, L., Finger, E., Martinez-A, C., Siegelman, M. H., Cybulsky, M., & Gutierrez-Ramos, J. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119045 · Cited by 427
Interleukin-4 Receptor in Moderate Atopic Asthma: A Phase I/II Randomized, Placebo-controlled Trial
BORISH, L. C., NELSON, H. S., LANZ, M. J., CLAUSSEN, L., WHITMORE, J. B., AGOSTI, J. M., & GARRISON, L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9808146 · Cited by 418
Irusen, E., Matthews, J. G., Takahashi, A., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122465 · Cited by 416
Self-citationDurham, S. R., Ying, S., Varney, V. A., Jacobson, M. R., Sudderick, R. M., Mackay, I. S., Kay, A. B., & Hamid, Q. A. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70205-1 · Cited by 412
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
Borish, L. C., Nelson, H. S., Corren, J., Bensch, G., Busse, W. W., Whitmore, J. B., & Agosti, J. M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.115624 · Cited by 411
Ying, S., Meng, Q., Zeibecoglou, K., Robinson, D. S., Macfarlane, A., Humbert, M., & Kay, A. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6321 · Cited by 411
IL-4/IL-13 signaling beyond JAK/STAT
Jiang, H., Harris, M. B., & Rothman, P. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107604 · Cited by 396
Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N. J., Donaldson, D. D., DeKruyff, R. H., & Umetsu, D. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4668 · Cited by 396
Sur, S., Wild, J. S., Choudhury, B. K., Sur, N., Alam, R., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6284 · Cited by 384
Bryan, S. A., O'Connor, B. J., Matti, S., Leckie, M. J., Kanabar, V., Khan, J., Warrington, S. J., Renzetti, L., Rames, A., Bock, J. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03497-8 · Cited by 383
Self-citationPhosphodiesterase inhibitors: new opportunities for the treatment of asthma.
Torphy, T. J., & Undem, B. J. (1991) · Thorax · doi:10.1136/thx.46.7.512 · Cited by 380
How Do Corticosteroids Work in Asthma?
Barnes, P. J., & Adcock, I. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00012 · Cited by 371
Self-citationThe Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry Air
Israel, E., Dermarkarian, R., Rosenberg, M., Sperling, R., Taylor, G., Rubin, P., & Drazen, J. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232505 · Cited by 370
Jin, S.-L. C., & Conti, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122041599 · Cited by 367
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Economides, A. N., Carpenter, L. R., Rudge, J. S., Wong, V., Koehler-Stec, E. M., Hartnett, C., Pyles, E. A., Xu, X., Daly, T. J., Young, M. R., et al. (2003) · Nature Medicine · doi:10.1038/nm811 · Cited by 359
A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties
Thurmond, R. L., Desai, P. J., Dunford, P. J., Fung-Leung, W.-P., Hofstra, C. L., Jiang, W., Nguyen, S., Riley, J. P., Sun, S., Williams, K. N., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061754 · Cited by 351
Oldfield, W., Larché, M., & Kay, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09332-7 · Cited by 347
Spector, S. L., Smith, L. J., & Glass, M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.3.8087328 · Cited by 341
JOHN, M., LIM, S., SEYBOLD, J., JOSE, P., ROBICHAUD, A., O'CONNOR, B., BARNES, P. J., & FAN CHUNG, K. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9703079 · Cited by 339
Self-citationTrial of cyclosporin in corticosteroid-dependent chronic severe asthma
Alexander, A. G., Kay, A. B., & Barnes, N. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)91646-p · Cited by 327
Effects of an antibody to interleukin-5 in a monkey model of asthma.
Mauser, P. J., Pitman, A. M., Fernandez, X., Foran, S. K., Adams, G. K., Kreutner, W., Egan, R. W., & Chapman, R. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633694 · Cited by 319
Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., & Resche-Rigon, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9979 · Cited by 311
Selective activation of Ca2+ -dependent K+ channels by novel benzimidazolone
Olesen, S.-P., Munch, E., Moldt, P., & Drejer, J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90442-1 · Cited by 302
Lloyd, C. M., Delaney, T., Nguyen, T., Tian, J., Martinez-A, C., Coyle, A. J., & Gutierrez-Ramos, J.-C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.265 · Cited by 300
Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H., Downward, J., & Tybulewicz, V. L. J. (1996) · PubMed · Cited by 290
Hsu, C.-H., Chua, K.-Y., Tao, M.-H., Lai, Y.-L., Wu, H.-D., Huang, S.-K., & Hsieh, K.-H. (1996) · Nature Medicine · doi:10.1038/nm0596-540 · Cited by 285
Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells
Longphre, M., Li, D., Gallup, M., Drori, E., Ordoñez, C. L., Redman, T., Wenzel, S., Bice, D. E., Fahy, J. V., & Basbaum, C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6097 · Cited by 283
IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma
Shimbara, A., Christodoulopoulos, P., Soussi-Gounni, A., Olivenstein, R., Nakamura, Y., Levitt, R. C., Nicolaides, N. C., Holroyd, K. J., Tsicopoulos, A., Lafitte, J.-J., et al. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90185-4 · Cited by 281
ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses
Gonzalo, J. A., Tian, J., Delaney, T., Corcoran, J., Rottman, J. B., Lora, J., Al-garawi, A., Kroczek, R., Gutierrez-Ramos, J. C., & Coyle, A. J. (2001) · Nature Immunology · doi:10.1038/89739 · Cited by 279
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
Zuany-Amorim, C., Hailé, S., Leduc, D., Dumarey, C., Huerre, M., Vargaftig, B. B., & Pretolani, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117966 · Cited by 276
Theophylline in the management of asthma: time for reappraisal?
Barnes, P. J., & Pauwels, R. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07030579 · Cited by 272
Self-citationEffect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide.
Yates, D. H., Kharitonov, S. A., Robbins, R. A., Thomas, P. S., & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663801 · Cited by 272
Self-citationKnight, D. A., Lim, S., Scaffidi, A. K., Roche, N., Chung, K. F., Stewart, G. A., & Thompson, P. J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.119025 · Cited by 269
Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy.
Kidney, J., Dominguez, M., Taylor, P. M., Rose, M., Chung, K. F., & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.6.7767539 · Cited by 262
Self-citationGuo, F. H., Comhair, S. A. A., Zheng, S., Dweik, R. A., Eissa, N. T., Thomassen, M. J., Calhoun, W., & Erzurum, S. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5970 · Cited by 259
DNA antisense therapy for asthma in an animal model
Nyce, J. W., & Metzger, W. J. (1997) · Nature · doi:10.1038/385721a0 · Cited by 257
Muscarinic receptor subtypes in airways
Barnes, P. J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90310-y · Cited by 255
Self-citationTh2 cytokines and asthma The role of interleukin-5 in allergic eosinophilic disease
Greenfeder, S., Umland, S. P., Cuss, F. M., Chapman, R. W., & Egan, R. W. (2001) · Respiratory Research · doi:10.1186/rr41 · Cited by 243
Zhang, X., Shan, P., Jiang, D., Noble, P. W., Abraham, N. G., Kappas, A., & Lee, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312941200 · Cited by 241
Herz, U., Gerhold b, K., Grüber b, C., Braun a, A., Wahn, U., Renz, H., & Paul, K. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70030-2 · Cited by 238
Platelet-activating factor as a mediator of allergic disease
Barnes, P. J., Chung, K. F., & Page, C. P. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90952-9 · Cited by 229
Self-citationYousefi, S., Hoessli, D. C., Blaser, K., Mills, G. B., & Simon, H. U. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1407 · Cited by 228
Oh, J.-W., Seroogy, C. M., Meyer, E. H., Akbari, O., Berry, G., Fathman, C. G., DeKruyff, R. H., & Umetsu, D. T. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.127512 · Cited by 219
Inhibitory Effect of the TRFK-5 Anti-IL-5 Antibody in a Guinea Pig Model of Asthma
Mauser, P. J., Pitman, A., Witt, A., Fernandez, X., Zurcher, J., Kung, T., Jones, H., Watnick, A. S., Egan, R. W., Kreutner, W., et al. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.6_pt_1.1623 · Cited by 218
Tattersfield, A., Knox, A., Britton, Jr., & Hall, I. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11312-2 · Cited by 213
Compton, C. H., Gubb, J., Nieman, R., Edelson, J., Amit, O., Bakst, A., Ayres, J. G., Creemers, J. P., Schultze-Werninghaus, G., Brambilla, C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05481-2 · Cited by 208
Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.
Clark, J. M., Abraham, W. M., Fishman, C. E., Forteza, R., Ahmed, A., Cortes, A., Warne, R. L., Moore, W. R., & Tanaka, R. D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520778 · Cited by 208
Hansel, T. T., Kharitonov, S. A., Donnelly, L. E., Erin, E. M., Currie, M. G., Moore, W. M., Manning, P. T., Recker, D. P., & Barnes, P. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0633fje · Cited by 208
Self-citationAMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity
Lukacs, N. W., Berlin, A., Schols, D., Skerlj, R. T., & Bridger, G. J. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62562-x · Cited by 207
Selective, Tight-Binding Inhibitors of Integrin α4β1 That Inhibit Allergic Airway Responses
Lin, K.-C., Ateeq, H. S., Hsiung, S. H., Chong, L. T., Zimmerman, C. N., Castro, A., Lee, W.-C., Hammond, C. E., Kalkunte, S., Chen, L.-L., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980673g · Cited by 207
Campbell, E. M., Charo, I. F., Kunkel, S. L., Strieter, R. M., Boring, L., Gosling, J., & Lukacs, N. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2160 · Cited by 207
Nebulized IFN-γ inhibits the development of secondary allergic responses in mice
Lack, G., Bradley, K. L., Hamelmann, E., Renz, H., Loader, J., Leung, D. Y., Larsen, G., & Gelfand, E. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1432 · Cited by 205
Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice
Gavett, S. H., O'Hearn, D. J., Karp, C. L., Patel, E. A., Schofield, B. H., Finkelman, F. D., & Wills-Karp, M. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.2.l253 · Cited by 200
Belvisi, M. G., Wicks, S. L., Battram, C. H., Bottoms, S. E. W., Redford, J. E., Woodman, P., Brown, T. J., Webber, S. E., & Foster, M. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1975 · Cited by 186
Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
Suttorp, N., Weber, U., Welsch, T., & Schudt, C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116346 · Cited by 186
Cheng, G., Arima, M., Honda, K., Hirata, H., Eda, F., Yoshida, N., Fukushima, F., Ishii, Y., & Fukuda, T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105079 · Cited by 184
Small RNA: can RNA interference be exploited for therapy?
Wall, N. R., & Shi, Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14637-5 · Cited by 180
Wills-Karp, M., & Chiaramonte, M. (2003) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200301000-00004 · Cited by 179
Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
Evans, D. J., Barnes, P. J., Spaethe, S. M., van Alstyne, E. L., Mitchell, M. I., & O'Connor, B. J. (1996) · Thorax · doi:10.1136/thx.51.12.1178 · Cited by 175
Self-citationKim, T. S., DeKruyff, R. H., Rupper, R., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4137 · Cited by 170
Kume, H., Graziano, M. P., & Kotlikoff, M. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11051 · Cited by 168
Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation
He, S., & Walls, A. F. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)83033-6 · Cited by 167
Nasuhara, Y., Adcock, I. M., Catley, M., Barnes, P. J., & Newton, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19965 · Cited by 162
Self-citationThe Function Role of GATA-3 in Th1 and Th2 Differentiation
Zhou, M., & Ouyang, W. (2003) · Immunologic Research · doi:10.1385/ir:28:1:25 · Cited by 153
Krishna, M. T., Chauhan, A., Little, L., Sampson, K., Hawksworth, R. J., Mant, T., Djukanović, R., Lee, T. H., & Holgate, S. T. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.115631 · Cited by 152
Santeliz, J., Nest, G. V., Traquina, P., Larsen, E., & Wills-Karp, M. A. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122156 · Cited by 150
Improvement of symptoms of non‐allergic chronic rhinitis by local treatment with capsaicin
Lacroix, J. S., Buvelot, J.-M., Polla, B. S., & Lundberg, J. M. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb00852.x · Cited by 147
Expression and regulation of human and rat phosphodiesterase type IV isogenes
Engels, P., Fichtel, K., & Lübbert, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00788-8 · Cited by 137
Kinase regulation in inflammatory response
Delhase, M., Li, N., & Karin, M. (2000) · Nature · doi:10.1038/35019154 · Cited by 133
Biologic activities of IL-1 and its role in human disease
Essayan, D. M., Fox, C. C., Levi‐Schaffer, F., Alam, R., & Rosenwasser, L. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70118-6 · Cited by 130
Sousa, A. R., Lane, S. J., Nakhosteen, J. A., Lee, T. H., & Poston, R. N. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887608 · Cited by 127
Inhibition of Allergic Inflammation in the Airways Using Aerosolized Antisense to Syk Kinase
Stenton, G. R., Ulanova, M., Déry, R. E., Merani, S., Kim, M.-K., Gilchrist, M., Puttagunta, L., Musat‐Marcu, S., James, D., Schreiber, A. D., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1028 · Cited by 124
Treatment of established asthma in a murine model using CpG oligodeoxynucleotides
Kline, J. N., Kitagaki, K., Businga, T. R., & Jain, V. V. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00402.2001 · Cited by 124
Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions
Gutierrez‐Ramos, J. C., Lloyd, C. M., & Gonzalo, J. A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01522-4 · Cited by 123
Need for theophylline in severe steroid‐requiring asthmatics
BRENNER, M., BERKOWITZ, R., Marshall, N., & Strunk, R. C. (1988) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1988.tb02853.x · Cited by 120
Fozard, J. R., Ellis, K. M., Dantas, M. F., Tigani, B., & Mazzoni, L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01305-5 · Cited by 117
IL-9 pathway in asthma: New therapeutic targets for allergic inflammatory disorders
Levitt, R. C., McLane, M. P., MacDonald, D., Ferrante, V., Weiss, C., Zhou, T., Holroyd, K. J., & Nicolaides, N. C. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70165-x · Cited by 111
Chung, C. D., Kuo, F., Kumer, J. L., Motani, A. S., Lawrence, C. E., Henderson, W. R., & Venkataraman, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.581 · Cited by 109
The potential role of tumour necrosis factor a in asthma
KIPS, J. C., Tavernier, J. H., Joos, G. F., Peleman, R. A., & Pauwels, R. (1993) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1993.tb00317.x · Cited by 108
New Immunosuppressive Drugs: Mechanistic Insights and Potential Therapeutic Advances
Thomson, A. W., & Starzl, T. E. (1993) · Immunological Reviews · doi:10.1111/j.1600-065x.1993.tb00655.x · Cited by 108
Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves.
Stretton, D., Miura, M., Belvisi, M., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1325 · Cited by 106
Anti-CD86 (B7.2) Treatment Abolishes Allergic Airway Hyperresponsiveness in Mice
Haczku, A., Takeda, K., Redai, I. G., Hamelmann, E. H., Cieslewicz, G., Joetham, A., Loader, J. E., Lee, J. J., Irvin, C. G., & Gelfand, E. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9711040 · Cited by 106
Sousa, A. R., Lane, S. J., Soh, C., & Lee, T. H. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70325-8 · Cited by 102
van Oosterhout, A. J. M., Hofstra, C. L., Shields, R. L., Chan, B., van Ark, I., Jardieu, P. M., & Nijkamp, F. P. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.3.2679 · Cited by 96
Treatment of steroid-dependent bronchial asthma with cyclosporin
Nizankowska, E., Soja, J., Pinis, G., Bochenek, G., Sładek, K., Domagala, B., Pajak, A., & Szczeklik, A. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08071091 · Cited by 96
BUGEON, L., & DALLMAN, M. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.supplement_3.15tac5 · Cited by 94
Simon, H., Seelbach, H., Ehmann, R., & Schmitz, M. (2003) · Allergy · doi:10.1046/j.1398-9995.2003.00424.x · Cited by 94
ATP Modulates Anti-IgE–Induced Release of Histamine from Human Lung Mast Cells
Schulman, E. S., Glaum, M. C., Post, T., Wang, Y., Raible, D. G., Mohanty, J. G., Butterfield, J. H., & Pelleg, A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.3.3387 · Cited by 93
Th2 cytokines and asthma — Interleukin-9 as a therapeutic target for asthma
Zhou, Y., McLane, M. P., & Levitt, R. C. (2001) · Respiratory Research · doi:10.1186/rr42 · Cited by 88
Kuss, H., Hoefgen, N., Johanssen, S., Kronbach, T., & Rundfeldt, C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053942 · Cited by 87
Molecular therapy to inhibit NFκB activation by transcription factor decoy oligonucleotides
Morishita, R., Tomita, N., Kaneda, Y., et al. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.008 · Cited by 87
Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease
Erin, B. S. P. E. M., Williams, B. S. P. T. J., Barnes, B. S. P. P. J., & Hansel, B. S. P. T. T. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344715 · Cited by 84
Brunnée, T., Engelstätter, R., Steinijans, V., et al. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05080982 · Cited by 84
Medicinal chemistry and therapeutic potential of CpG DNA
Agrawal, S., & Kandimalla, E. R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02264-x · Cited by 83
Chan, S. C., Reifsnyder, D. H., Beavo, J. A., & Hanifin, J. M. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90321-6 · Cited by 82
Effect of Theophylline and Adenosine on Eosinophil Function
Yukawa, T., Kroegel, C., Chanez, P., Dent, G., Ukena, D., Chung, K. F., & Barnes, P. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.2.327 · Cited by 78
Self-citationAmoui, M., Dráber, P., & Dráberová, L. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270810 · Cited by 78
Schafer, P. H., Wadsworth, S. A., Wang, L., & Siekierka, J. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7110 · Cited by 76
Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)
Rabinowitz, M. H., Andrews, R. C., Becherer, J. D., Bickett, D. M., Bubacz, D. G., Conway, J. G., Cowan, D. J., Gaul, M. D., Glennon, K. C., Lambert, M. H., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102654 · Cited by 73
Cookson, W. (2002) · CHEST Journal · doi:10.1378/chest.121.3_suppl.7s-a · Cited by 73
Effect of a Novel Potent Platelet-Activating Factor Antagonist, Modipafant, in Clinical Asthma
Kuitert, L. M. E., Angus, R., Barnes, N. C., Barnes, P. J., Bone, M. F., Chung, K. F., Fairfax, A. J., Higenbotham, T. W., O'Connor, B. J., & Piotrowska, B. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735582 · Cited by 70
Self-citationSaban, R., Haak‐Frendscho, M., Zine, M., Ridgway, J. B., Gorman, C., Presta, L. G., Bjorling, D. E., Saban, M., & Jardieu, P. M. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90151-1 · Cited by 68
Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint disease
Roshak, A. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00165-0 · Cited by 64
Gruetter, C. A., Childers, C. E., Bosserman, M. K., Lemke, S. M., Ball, J. G., & Valentovic, M. A. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.5.1192 · Cited by 64
van Neerven, R. J. J., van de Pol, M. A., van der Zee, J. S., Stiekema, Boer, D., & Kapsenberg (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00306.x · Cited by 63
Bronchodilator effect of atrial natriuretic peptide in asthma.
Hulks, G., Jardine, A. G., Connell, J. M. C., & Thomson, N. C. (1989) · BMJ · doi:10.1136/bmj.299.6707.1081 · Cited by 59
CTLA4-IgG Reverses Asthma Manifestations in a Mild but Not in a More “Severe” Ongoing Murine Model
Deurloo, D. T., van Esch, B. C. A. M., Hofstra, C. L., Nijkamp, F. P., & van Oosterhout, A. J. M. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.6.4607 · Cited by 59
Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma
Lindén, A., Hansson, L., Andersson, A., Palmqvist, M., Arvidsson, P., Löfdahl, C.-G., Larsson, P., & Lötvall, J. (2003) · Thorax · doi:10.1136/thorax.58.3.217 · Cited by 59
Long- Versus Short-Acting ??2-Agonists: Implications for Drug Therapy
Boulet, L. (1994) · Drugs · doi:10.2165/00003495-199447020-00001 · Cited by 57
Mohanty, J. G., Raible, D. G., McDermott, L. J., Pelleg, A., & Schulman, E. S. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.114658 · Cited by 53
IL‐10: a key regulator of allergic disease
Barnes, P. J. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01118.x · Cited by 51
Self-citationInduction of non-responsiveness in human allergen-specific type 2 T helper cells
Yssel, H., Fasler, S., Lamb, J. R., & de Vries, J. E. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90003-5 · Cited by 51
Inhibitory cytokines in asthma
Barnes, P. J., & Lim, S. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01335-5 · Cited by 48
Self-citationBarnes, P. J., Holgate, S. T., Laitinen, L. A., & Pauwels, R. (1995) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1995.tb00016.x · Cited by 48
Self-citationCell Adhesion Molecules in Asthma: Homing, Activation, and Airway Remodeling
Pilewski, J. M., & Albelda, S. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.1.7811464 · Cited by 48
Reynolds, N. A., & Scott, L. J. (2004) · Drugs · doi:10.2165/00003495-200464050-00005 · Cited by 43
STAT6: an intracellular target for the inhibition of allergic disease
oster, F. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00476.x · Cited by 42
An immune cell-selective interleukin 4 agonist
Shanafelt, A. B., Forte, C. P., Kasper, J. J., Sanchez-Pescador, L., Wetzel, M., Gundel, R. H., & Greve, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9454 · Cited by 41
Chilvers, E. R., Challiss, R. A. J., WILLCOCKS, A. L., Potter, B. V. L., Barnes, P. J., & Nahorski, S. R. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14698.x · Cited by 34
Self-citationDiscovery and Development of Respirable Antisense Therapeutics for Asthma
Sandrasagra, A., Leonard, S. A., Tang, L., Teng, K., Li, Y., Ball, H. A., Mannion, J. C., & Nyce, J. W. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220770 · Cited by 28
Kim, M.-K., Brandley, B. K., Anderson, M. B., & Bochner, B. S. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.5.3032 · Cited by 27
Anti-leukotrienes: here to stay?
Barnes, P. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00036-5 · Cited by 20
Self-citationSeldon, P. M., & Giembycz, M. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704238 · Cited by 17
Cited by
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation
Talbot, S., Abdulnour, R.-E. E., Burkett, P. R., Lee, S., Cronin, S. J. F., Pascal, M. A., Laedermann, C., Foster, S. L., Tran, J. V., Lai, N., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.007 · Cited by 452
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances: Miniperspective
Reis, J., Gaspar, A., Milhazes, N., & Borges, F. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01720 · Cited by 414
Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
Phosphodiesterases in the CNS: targets for drug development
Menniti, F. S., Faraci, W. S., & Schmidt, C. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2058 · Cited by 391
Metadata
- Authors
- Barnes, P. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-10
- Volume
- 3
- Issue
- 10
- Pages
- 831-844
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W283814565
- Cited by
- 280
- References
- 167
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.